Brighter AB (publ) is pleased to announce that Dr Teddy Batanghari joins as Senior Advisor. Dr. Batanghari will advise Brighter on various matters, including those related to the market introduction of Actiste in and beyond Indonesia. Dr Batanghari is based in Jakarta, Indonesia, where he is the former CEO of Summit Healthcare, the region's leading medical training and simulation company, dedicated to the advancement of healthcare professionals and continuing health education in Indonesia and also founding partner of Kairos Healthcare, an innovative medtech distribution company in Indonesia.
Dr Batanghari has deep experience in many corners of the healthcare industry as well as in the financial industry. He graduated with a BA in Bioengineering at the University of California San Diego in 1984, became Medical Doctor four years later at Washington University Medical School in St. Louis and obtained US Board certification in Pediatrics as well as had clinical training in Pediatric Endocrinology at St Louis Children's Hospital, and received a MBA in International Finance and Health Care Management at Northwestern University, Kellogg School of Management in 1995.
Dr. Batanghari has, among other positions, served as CEO of the prestigious Indonesian hospital Pandai Indah Kapuk for 18 years, and was appointed CEO of Summit Healthcare in 2016 and of Kairos Healthcare in 2017. Summit Healthcare has a very strong presence in the Indonesian diabetes market, with several certified programs. Kairos Healthcare is a medical device distribution company geared to bring innovative, cost efficient, and impactful technology for the Indonesian mass market. Dr. Batanghari is one of the founding partners of Kairos Healthcare.
"I'm pleased to work with Brighter, as the company not only have brilliant technology and vision, but is very committed to helping people with diabetes in Indonesia." says Dr. Batanghari.
Indonesia is the world's fourth largest country by population and is deeply hit by diabetes. Estimates from the International Diabetes Foundation predict that Diabetes will grow by 64% in Indonesia at 2045. Brighter is a partner in Mampu Indonesia, a private public partnership ("PPP)" with the Indonesian government to help curb the spreading of diabetes.
"Teddy is a valuable advisor for us, as he knows everything about and everyone in the healthcare sector in Indonesia. I'm very happy to be able to consult him on a regular basis, says Brighter's CEO and founder Truls Sjöstedt.
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare's biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Actiste is connected via an autonomous and secure mobile connection, the information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed.
Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives ' concerns, and release enormous healthcare resources. www.actiste.com
The Company's shares are listed on NASDAQOMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375).
Visit our website and subscribe to press releases: www.brighter.se (http://brighter.se/en/press/press-releases/)
Follow us on: (http://www.facebook.com/brightercompany)
(https://www.linkedin.com/company/brighter-ab) (https://twitter.com/brighterinnov) (https://www.facebook.com/brighterinnovation) (http://google.com/+BrighterInnovation) (https://www.youtube.com/c/BrighterInnovation) (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375)
Brighter's Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 - 684 211 00, email@example.com, www.eminova.se.
For further information, please contact:
This information was distributed by Cision http://www.cisionwire.se/